Shanghai MicuRx Pharmaceutical Co., Ltd. (SHA:688373)

China · Delayed Price · Currency is CNY

4.490

-0.040 (-0.88%)

At close: Jun 11, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Research and Development of Drugs and Other Businesses	141.77M	130.27M	90.78M	48.21M	7.66M
Research and Development of Drugs and Other Businesses Growth	8.83%	43.51%	88.31%	529.33%	-
Total	141.77M	130.27M	90.78M	48.21M	7.66M
Total Growth	8.83%	43.51%	88.31%	529.33%	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
China	141.69M	-	-	-	-
Total	141.69M	-	-	-	-

Source: S&P Global Market Intelligence.